IC
BMRN icon

IEQ Capital’s BioMarin Pharmaceuticals BMRN Stock Holding History

IEQ Capital’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22.7M Buy
401,610
+43,554
+12% +$2.54M 0.11% 187
2025
Q4 		$21.3M Sell
358,056
-61,265
-15% -$3.34M 0.06% 198
2025
Q3 		$22.7M Buy
419,321
+163,702
+64% +$9.36M 0.07% 150
2025
Q2 		$14.1M Buy
255,619
+91,043
+55% +$5.36M 0.09% 177
2025
Q1 		$11.6M Buy
164,576
+104,289
+173% +$7.02M 0.09% 172
2024
Q4 		$3.96M Buy
60,287
+53,151
+745% +$3.56M 0.04% 325
2024
Q3 		$502K Buy
+7,136
New +$596K 0.01% 749

Other funds holding BMRN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

IEQ Capital's BMRN Position: Q1 2026 in Review

IEQ Capital increased its BioMarin Pharmaceuticals (BMRN) stake by 12% in Q1 2026, buying an estimated $2.54M and bringing the position to 401,610 shares worth $22.7M. The position accounts for 0.11% of the portfolio, ranked #187.

IEQ Capital first reported a position in BMRN in Q3 2024 and has held it in 7 quarters since. The position peaked at $22.7M in Q3 2025. 554 funds tracked by Wall St. Rank hold BMRN as of Q1 2026.

  • IEQ Capital held 401,610 shares of BioMarin Pharmaceuticals worth $22.7M as of Q1 2026.
  • IEQ Capital bought 43,554 BioMarin Pharmaceuticals shares in Q1 2026, an estimated $2.54M.
  • BioMarin Pharmaceuticals made up 0.11% of IEQ Capital's portfolio in Q1 2026, its #187 holding.
  • IEQ Capital first reported a position in BioMarin Pharmaceuticals in Q3 2024 and has held it in 7 quarters since.
  • IEQ Capital's BioMarin Pharmaceuticals position peaked at $22.7M in Q3 2025.
  • 554 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2026.

Based on IEQ Capital's 13F filing for Q1 2026, filed 15 May 2026.